Aozasa K, Ohsawa M, Horiuchi K, Myoui A, Kawano K
Department of Pathology, Nara Medical Univeristy, Kashihara, Japan.
J Surg Oncol. 1991 Dec;48(4):268-71. doi: 10.1002/jso.2930480410.
The nature of intermediate lymphocytic lymphoma (ILL) in Japan was investigated. For this purpose, we have reviewed 1,766 cases of malignant lymphoma and related diseases, and 38 cases were selected as ILL. In two cases, small lymphoid cells proliferated as a wide mantle of atrophic secondary follicles. The frequency of ILL in nodal and extranodal non-Hodgkin's lymphoma was 3.4% and 3.9%, respectively. The frequency was high in orbit and salivary gland lymphomas; two out of three cases and one out of six cases, respectively. Age range (median) and sex ratio (M:F) in nodal and extranodal cases were 34-65 (52) years and 2.1:1 and 22-82 (61) years and 1.1:1, respectively. The majority of nodal ILL presented as systemic disease, but extranodal ILL usually presented as localized disease. ILL when treated with chemotherapy and/or radiotherapy had a favorable prognosis, the 5-year survival rate was 82%.
对日本间变性淋巴细胞淋巴瘤(ILL)的性质进行了调查。为此,我们回顾了1766例恶性淋巴瘤及相关疾病病例,其中38例被选为ILL。在2例中,小淋巴细胞在萎缩的次级滤泡的宽大套区增殖。ILL在淋巴结和结外非霍奇金淋巴瘤中的发生率分别为3.4%和3.9%。在眼眶和涎腺淋巴瘤中发生率较高;分别为三分之二的病例和六分之一的病例。淋巴结和结外病例的年龄范围(中位数)和性别比(男:女)分别为34 - 65(52)岁和2.1:1以及22 - 82(61)岁和1.1:1。大多数淋巴结ILL表现为全身性疾病,但结外ILL通常表现为局限性疾病。ILL经化疗和/或放疗治疗后预后良好,5年生存率为82%。